IPG Photonics Announces Binding Offer to Acquire Lumibird Medical, Expanding IPG’s Medical Laser Growth Platform
IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million in cash, plus an additional €50 million earnout based on 2026 and 2027 performance metrics. The acquisition creates a scaled medical laser platform by combining Lumibird’s ophthalmology leadership with IPG’s urology strength, adding approximately $1 billion in addressable market.
Key figures
- Guidance
- Transaction expected to be accretive to gross margin, EBITDA and adjusted EPS
- Deal Value Usd
- €300 million
- Earnout potential
- €50 million
- Target ebitda margin
- 21.5%
- Target fy2025 ebitda
- €24.1 million
- Target fy2025 revenue
- €112.2 million
- Addressable market added
- $1 billion
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.